Search Filters

Sponsors/Funders See All +

Phase See All +

Medical Condition See All +

Medicine See All +

This is a keyword search. It will find studies with your keywords in the study information.
To find studies using the keyword search, enter your keyword search term below, e.g. "lung cancer" or a trial identification number.
You can also search studies by Sponsor/Funder, Phase, Medical Condition or Medicine by using the search filters on the left.

Keyword Search Clear All

To initiate a Research Proposal or to Ask a Question about studies, please do the following:

Login and create an account.
Click on the Study ID to view Study Details.
If you cannot find the specific study you are looking for, click here to submit an Enquiry

Export All Studies >

3237 Results:

Sponsor	Studies ↑	Description	Ready to Share	Created

Bayer	*BAYER-15786	A randomized controlled trial of rivaroxaban for the prevention of major cardiovascular events in patients with coronary or peripheral artery disease (COMPASS - Cardiovascular OutcoMes for People using Anticoagulation StrategieS).	No	4/18/2019

Eisai	*EISAI-E2007-A001-206	A Double-Blind, Placebo-Controlled, Dose-Escalation, Parallel-Group Study of E2007 Given as Adjunctive Therapy in Patients With Refractory Partial Seizures	No	11/30/2018

Eisai	*EISAI-E2007-G000-235	A Randomized, Double-blind, Placebo-controlled, Parallel-group Study With an Open-label Extension Phase to Evaluate the Effect of Perampanel (E2007) on Cognition, Growth, Safety, Tolerability, and Pharmacokinetics When Administered as an Adjunctive Therapy in Adolescents (12 to Less Than 18 Years of Age) With Inadequately Controlled Partial-onset Seizures	No	11/30/2018

Eisai	*EISAI-E2007-G000-304	A Double-Blind, Placebo-Controlled, Dose-Escalation, Parallel-Group Study to Evaluate the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures	No	11/30/2018

Eisai	*EISAI-E2007-G000-305	A Double-Blind, Placebo-Controlled, Dose-Escalation, Parallel-Group Study to Evaluate the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures	No	11/30/2018

Eisai	*EISAI-E2007-G000-306	A Double-Blind, Placebo-Controlled, Dose-Escalation, Parallel-Group Study to Evaluate the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures	No	11/30/2018

Eisai	*EISAI-E2007-G000-332	A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures	No	11/30/2018

Eisai	*EISAI-E2007-G000-332EXT	A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures	No	11/30/2018

Eisai	*EISAI-E2007-J000-335	A Double-blind, Placebo-controlled, Parallel-group Study With an Open-label Extension Phase to Evaluate the Efficacy and Safety of Perampanel (E2007) Administered as an Adjunctive Therapy in Subjects With Refractory Partial-onset Seizures	No	11/30/2018

Eisai	*EISAI-E2080-G000-303	A Multicenter, Randomized, Controlled, Open-label Study to Evaluate the Cognitive Development Effects and Safety, and Pharmacokinetics of Adjunctive Rufinamide Treatment in Pediatric Subjects 1 to Less Than 4 Years of Age With Inadequately Controlled Lennox-Gastaut Syndrome	No	11/30/2018

First 1 2 3 4 5 ... Last